Prediction of Hepatic Metabolic Clearance
- 1 January 2001
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 40 (7), 553-563
- https://doi.org/10.2165/00003088-200140070-00006
Abstract
To perform a comparative quantitative evaluation of the prediction accuracy for human hepatic metabolic clearance of 5 different mathematical models: allometric scaling (multiple species and rat only), physiologically based direct scaling, empirical in vitro-in vivo correlation, and supervised artificial neural networks. The mathematical prediction models were implemented with a publicly available dataset of 22 extensively metabolised compounds and compared for their prediction accuracy using 3 quality indicators: prediction error sum of squares (PRESS), r2 and the fold-error. Approaches such as physiologically based direct scaling, empirical in vitro-in vivo correlation and artificial neural networks, which are based on in vitro data only, yielded an average fold-error ranging from 1.64 to 2.03 and r2 values greater than 0.77, as opposed to r2 values smaller than 0.44 when using allometric scaling combining in vivo and in vitro preclinical data. The percentage of successful predictions (less than 2-fold error) ranged from 55% (rat allometric scaling) to between 64 and 68% with the other approaches. On the basis of a diverse set of 22 metabolised drug molecules, these studies showed that the most cost-effective and accurate approaches, such as physiologically based direct scaling and empirical in vitro-in vivo correlation, are based on in vitro data alone. Inclusion of in vivo preclinical data did not significantly improve prediction accuracy; the prediction accuracy of the allometric approaches was at the lower end of all methods compared.Keywords
This publication has 30 references indexed in Scilit:
- A COMMENTARY ON THE USE OF HEPATOCYTES IN DRUG METABOLISM STUDIES DURING DRUG DISCOVERY AND DEVELOPMENT*Drug Metabolism Reviews, 2000
- Utility of hepatocytes to model species differences in the metabolism of loxtidine and to predict pharmacokinetic parameters in rat, dog and manXenobiotica, 1999
- Prediction of Hepatic Metabolic Clearance Based on Interspecies Allometric Scaling Techniques and In Vitro-In Vivo CorrelationsClinical Pharmacokinetics, 1999
- QUANTITATIVE PREDICTION OF IN VIVO DRUG CLEARANCE AND DRUG INTERACTIONS FROM IN VITRO DATA ON METABOLISM, TOGETHER WITH BINDING AND TRANSPORTAnnual Review of Pharmacology and Toxicology, 1998
- Artificial Neural Networks As a Novel Approach to Integrated Pharmacokinetic—Pharmacodynamic AnalysisJournal of Pharmaceutical Sciences, 1996
- Interspecies scaling of tolcapone, a new inhibitor of catechol-O-methyltransferase (COMT). Use ofin vitrodata from hepatocytes to predict metabolic clearance in animals and humansXenobiotica, 1996
- The Backpropagation Neural Network - A Bayesian ClassifierClinical Pharmacokinetics, 1995
- An Interpretation of Partial Least SquaresJournal of the American Statistical Association, 1994
- Man versus Beast: Pharmacokinetic Scaling in MammalsJournal of Pharmaceutical Sciences, 1986
- Interspecies Pharmacokinetic Scaling and the Evolutionary-Comparative ParadigmDrug Metabolism Reviews, 1984